Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | OTHER_GOV |
Not provided
Not provided
Not provided
CoHPT is a prospective, monocentric, observational cohort including all patients diagnosed with primary hyperparathyroidism in Nantes University Hospital, aiming to study the outcomes associated with parathyroidectomy. Clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. A biocollection is collected. The main hypotheses are that parathyroidectomy could improve cardiovascular, renal, bone, and cardiovascular outcomes along with quality of life.
Primaty hyperparathyroidism is the third most frequent endocrine disorder, which only curative treatment is the parathyroidectomy (approximately 8000/year). However, evidences suggest that the mildest forms of PHPT could be safely monitored with simple surveillance. However, to define surgical indications is challenging because data regarding the impach of surgery on several outcomes (namely cardiovascular, bone, renal or quality of life) are controversial.
CoHPT is a prospective, monocentric, observational cohort including all consecutive patients diagnosed with sporadic primary hyperparathyroidism in Nantes University Hospital aiming to study the outcomes associated with parathyroidectomy. Patients are followed even if surgery is not performed.
A systematic clinical and biochemical evaluation is performed at the inclusion, and 6, 12, 36 and 60 months. These informations include demographic and general medical data, pre-operative imaging exams, post-operative outcomes, histopathological analysis, evaluation of the impact of primary hyperparathyroidism and its surgery on target organs (bone, kidney, cardiovascular) and quality of life. Fasting blood samples are also collected to constitute a biocollection, in order to measure biomarkers related to the bone remodeling and the cardiovascular risk.
The objectives are:
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of cardiovascular events, after parathyroidectomy for primary hyperparathyroidism | Cardiovascular events include myocardial infarction, cerebrovascular and peripheral arterial events | Between inclusion and 12 months after surgery |
| Change in LDL-cholesterol concentration after surgery | Plasma LDL-cholesterol (mg/dL) will be directly measured using enzymatic method | Between inclusion and 12 months after surgery |
| Change in HDL-cholesterol concentration after surgery | Plasma HDL-cholesterol (mg/dL) will be measured using enzymatic method | Between inclusion and 12 months after surgery |
| Change in plasma triglycerides concentration after surgery | Plasma triglycerides (mg/dL) will be measured using enzymatic method | Between inclusion and 12 months after surgery |
| Change in homeostasis model assessment HOMA-IR index after surgery | HOMA-IR is calculated using fasting plasma glucose and insulin level, with the following formula: (fasting plasma insulin (mIU/L) × fasting plasma glucose (mmol/L))/22.5 | Between inclusion and 12 months after surgery |
| Change in homeostasis model assessment HOMA-B index after surgery | HOMA-B is calculated using fasting plasma glucose and insulin level, with the following formula: 20 × fasting plasma insulin (mIU/L)/[fasting plasma glucose (mmol/L) - 3.5] | Between inclusion and 12 months after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Occurrence of cardiovascular events, after parathyroidectomy for primary hyperparathyroidism | Cardiovascular events include myocardial infarction, cerebrovascular and peripheral arterial events | Between inclusion and 60 months after surgery |
| Change in LDL-cholesterol concentration after surgery |
Not provided
Inclusion Criteria:
• Age > 18
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All consecutive patients consulting for sporadic primary hyperparathyroidism in Nantes University Hospital
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Eric MIRALLIE, PHD | Contact | 33 2 40 08 31 66 | eric.mirallie@chu-nantes.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Nantes University Hospital | Recruiting | Nantes | Loire-Atlantique | 44093 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41486083 | Derived | Loison M, Wargny M, Caillard C, Guillot P, Le Bras M, Cariou B, Blanchard C, Mirallie E, Frey S. Radius Bone Mineral Density Measurement Is Essential During Initial PHPT Workup: Results of a Retrospective Study on 400 Patients. World J Surg. 2026 Feb;50(2):441-450. doi: 10.1002/wjs.70223. Epub 2026 Jan 4. | |
| 36917123 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D049950 | Hyperparathyroidism, Primary |
| ID | Term |
|---|---|
| D006961 | Hyperparathyroidism |
| D010279 | Parathyroid Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in arterial stiffness after surgery |
Arterial stiffness is reflected by the measurement of the pulse wave velocity using the PoPmeter® instrument |
| Between inclusion and 12 months after surgery |
Plasma LDL-cholesterol (mg/dL) will be directly measured using enzymatic method |
| Between inclusion and 60 months after surgery |
| Change in HDL-cholesterol concentration after surgery | Plasma HDL-cholesterol (mg/dL) will be measured using enzymatic method | Between inclusion and 60 months after surgery |
| Change in plasma triglycerides concentration after surgery | Plasma triglycerides (mg/dL) will be measured using enzymatic method | Between inclusion and 60 months after surgery |
| Change in homeostasis model assessment HOMA-IR index after surgery | HOMA-IR is calculated using fasting plasma glucose and insulin level, with the following formula: (fasting plasma insulin (mIU/L) × fasting plasma glucose (mmol/L))/22.5 | Between inclusion and 60 months after surgery |
| Change in homeostasis model assessment HOMA-B index after surgery | HOMA-B is calculated using fasting plasma glucose and insulin level, with the following formula: 20 × fasting plasma insulin (mIU/L)/[fasting plasma glucose (mmol/L) - 3.5] | Between inclusion and 60 months after surgery |
| Change in arterial stiffness after surgery | Arterial stiffness is reflected by the measurement of the pulse wave velocity using the PoPmeter® instrument | Between inclusion and 60 months after surgery |
| Change in bone mineral density after parathyroidectomy | Bone mineral density is measured using Dual X-ray absorptiometry on lumbar spine, left hip, left femoral neck and left distal radius | Between inclusion and 12 months after surgery |
| Change in bone-specific alkaline phosphatases | Alkaline phosphatases (IU/L) are measured using ELISA enzymatic method | Between inclusion and 12 months after surgery |
| Change in P1NP | P1NP (µg/L) are measured using ELISA enzymatic method | Between inclusion and 12 months after surgery |
| Change in plasma CTX | CTX (µg/L) are measured using ELISA enzymatic method | Between inclusion and 12 months after surgery |
| Change in bone mineral density after parathyroidectomy | Bone mineral density is measured using Dual X-ray absorptiometry on lumbar spine, left hip, left femoral neck and left distal radius | Between inclusion and 60 months after surgery |
| Change in bone-specific alkaline phosphatases | Alkaline phosphatases (IU/L) are measured using ELISA enzymatic method | Between inclusion and 60 months after surgery |
| Change in P1NP | P1NP (µg/L) are measured using ELISA enzymatic method | Between inclusion and 60 months after surgery |
| Change in plasma CTX | CTX (µg/L) are measured using ELISA enzymatic method | Between inclusion and 60 months after surgery |
| Change in the physical component score of the SF-36 questionnaire after surgery | The physical component score is calculated from 4 items of the SF-36 questionnaire related to physical health. Results are expressed as a ratio between the included patients with values expected in an age- and sex-matched French reference population (available in Perneger T, Leplège A, Ecosse E. Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interprétation des scores; Paris: Editions Estem. 2001:1-156.) | Between inclusion and 36 months after surgery |
| Change in the mental component score of the SF-36 questionnaire after surgery | The mental component score is calculated from 4 items of the SF-36 questionnaire related to mental health. Results are expressed as a ratio between the included patients with values expected in an age- and sex-matched French reference population. | Between inclusion and 36 months after surgery |
| Change in the physical component score of the SF-36 questionnaire after surgery | The physical component score is calculated from 4 items of the SF-36 questionnaire related to physical health. Results are expressed as a ratio between the included patients with values expected in an age- and sex-matched French reference population (available in Perneger T, Leplège A, Ecosse E. Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interprétation des scores; Paris: Editions Estem. 2001:1-156.) | Between inclusion and 60 months after surgery |
| Change in the mental component score of the SF-36 questionnaire after surgery | The mental component score is calculated from 4 items of the SF-36 questionnaire related to mental health. Results are expressed as a ratio between the included patients with values expected in an age- and sex-matched French reference population. | Between inclusion and 60 months after surgery |
| Change in renal outcomes (estimated glomerular filtration rate) after parathyroidectomy | Estimated glomerular filtration rate will be calculated using the CKD-EPI equation from the measured serum creatinine | Between inclusion and 60 months after surgery |
| Medico-economic impact of parathyroidectomy for primary hyperparathyroidism in comparison with simple surveillance | Takes into account the incidence of the worsening of cardiac and bone comorbidities and surgical complications. Data will be cross-referenced by probabilistic matching with the data of the Système National d'Information Interrégimes d'Assurance Maladie (SNIIR-AM) | 60 months after surgery |
| Frey S, Perrot B, Caillard C, Le Bras M, Gerard M, Blanchard C, Cariou B, Wargny M, Mirallie E. Parathyroidectomy for primary hyperparathyroidism: effect on quality of life after 3 years - a prospective cohort study. Int J Surg. 2023 Mar 1;109(3):364-373. doi: 10.1097/JS9.0000000000000282. |